For example, TP53 mutations are relatively rare, seen in roughly 8–10% of NPC despite being among the frequent gene mutations identified alongside genes such as TRAF3, CYLD, NFKBIA [48,49,51]. This evidence concerns the gene TP53 and nasopharyngeal carcinoma.